Spyglass Pharma Inc (SGP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2006 | 12-2005 | 12-2004 | 12-2003 | 12-2002 | |
| Sales | 10,594,000 | 9,508,000 | 8,272,000 | 8,334,000 | 10,180,000 |
| Cost of Goods | 3,697,000 | 3,346,000 | 3,070,000 | 2,833,000 | 2,505,000 |
| Gross Profit | 6,897,000 | 6,162,000 | 5,202,000 | 5,501,000 | 7,675,000 |
| Operating Expenses | 6,906,000 | 6,239,000 | 5,418,000 | 4,943,000 | 5,106,000 |
| Operating Income | -9,000 | -77,000 | -216,000 | 558,000 | 2,569,000 |
| Other Income | 1,492,000 | 574,000 | 48,000 | -604,000 | -6,000 |
| Pre-tax Income | 1,483,000 | 497,000 | -168,000 | -46,000 | 2,563,000 |
| Income Tax | 362,000 | 228,000 | 779,000 | 46,000 | 589,000 |
| Net Income Continuous | 1,121,000 | 269,000 | -947,000 | -92,000 | 1,974,000 |
| Net Income | $1,143,000 | $269,000 | $-947,000 | $-92,000 | $1,974,000 |
| EPS Basic Total Ops | 0.71 | 0.12 | -0.67 | -0.06 | 1.35 |
| EPS Basic Continuous Ops | 0.69 | 0.12 | -0.67 | -0.06 | 1.35 |
| EPS Basic Discontinuous Ops | 0.02 | N/A | N/A | N/A | N/A |
| EPS Diluted Total Ops | 0.71 | 0.12 | -0.67 | -0.06 | 1.34 |
| EPS Diluted Continuous Ops | 0.69 | 0.12 | -0.67 | -0.06 | 1.34 |
| EBITDA(a) | $559,000 | $409,000 | $237,000 | $975,000 | $2,941,000 |